Assignee
REPLICOR INC
CA·11 granted patents·3 pending applications·65 citations·filing 2003–2021
Top patents by PatentIndex Score
14 records- 0190US8008269B2Antiviral oligonucleotidesREPLICOR INC·Filed 2008·Granted Aug 30, 2011·13 cites·45 claims
- 0289US7358068B2Antiviral oligonucleotidesREPLICOR INC·Filed 2003·Granted Apr 15, 2008·31 cites·2 claims
- 0387US8008270B2Antiviral oligonucleotides targeting viral familiesREPLICOR INC·Filed 2008·Granted Aug 30, 2011·9 cites·43 claims
- 0481US9133458B2Methods for the treatment of hepatitis B and hepatitis D infectionsREPLICOR INC·Filed 2013·Granted Sep 15, 2015·4 cites·55 claims
- 0579US9200283B2Methods for the treatment of hepatitis B and hepatitis D infectionsREPLICOR INC·Filed 2014·Granted Dec 1, 2015·3 cites·8 claims
- 0676US9616083B2Oligonucleotide chelate complex methodsREPLICOR INC·Filed 2013·Granted Apr 11, 2017·1 cites·28 claims
- 0774US8716259B2Oligonucleotide chelate complexesREPLICOR INC·Filed 2013·Granted May 6, 2014·2 cites·14 claims
- 0872US9533003B2Methods for the treatment of hepatitis B and hepatitis D infectionsREPLICOR INC·Filed 2015·Granted Jan 3, 2017·1 cites·13 claims
- 0968US9603865B2Methods for the treatment of hepatitis B and hepatitis D virus infectionsREPLICOR INC·Filed 2015·Granted Mar 28, 2017·1 cites·18 claims
- 1063US9284556B2Methods for the treatment of hepatitis B and hepatitis D infectionsREPLICOR INC·Filed 2014·Granted Mar 15, 2016·0 cites·9 claims
- 1160US2005196382A1Antiviral oligonucleotides targeting viral familiesREPLICOR INC·Filed 2004·Application pending·0 cites
- 1251US2007123480A1Oligonucleotides targeting prion diseasesREPLICOR INC·Filed 2004·Application pending·0 cites
- 1345US2023056788A1Methods and compositions for the inhibition of hepatitis b and hepatitis d virus infectionsREPLICOR INC·Filed 2021·Application pending·0 cites
- 1444US9492506B2Oligonucleotide chelate complex—polypeptide compositions and methodsREPLICOR INC·Filed 2013·Granted Nov 15, 2016·0 cites·46 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →